Small Caps Dashboard
 

CYCLOPHARM


Sector: Medical technology

Industry: Radiology services

This Australian med tech pioneer reminds us in many ways of one of our best recommendations in the sector, Medical Developments, which has delivered more than five-fold on our original investment.

Cyclopharm is positioned to grow its market substantially if it gains approval for sales into the US market. Its product Technegas has generated revenues in 57 countries. Over 195k patient procedures in 2018, 4.2m patient procedures since 1986.

With 1,600 Technegas generators sold globally, CYC’s underlying business is profitable and supports a small dividend.

There are at least 3m cases of Pulmonary Embolism globally each year. The company sells Technegas generators to radiology departments, and, on a recurring basis, the raw material (TN-99) in the form of 50 dose Patient Administration Sets (PAS).

**FY21 Forecast
 

See our recomndations.
Unlock

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec porttitor semper molestie. Ut eleifend, erat eu pulvinar iaculis, odio nunc venenatis tellus, ut placerat lorem purus sed tellus. Duis ut leo vitae massa facilisis dictum sed a dui. Proin quis pulvinar purus, vestibulum lobortis justo.

 
  • Radar Rating Unlock
  • Market Cap ($m)* 164.9
  • Dividend Yield (%)* 0.6
  • NET CASH ($M) 30
  • * Data as of 18 January 2022

Latest Research Summary

CYCLOPHARM: RESEARCH TIP UPDATE - JUNE 2021
03 Jun, 2021

Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Maecenas ut ex et est semper fringilla. Nam et lectus augue. Integer non consectetur ligula. Maecenas tortor metus, molestie at aliquam sit amet, feugiat sed ipsum. Donec vehicula mi ac neque tempor dignissim.

Unlock to view the latest research

Previous Research

Research Date Radar Rating  
CYCLOPHARM: RESEARCH TIP UPDATE - JUNE 2021 03 Jun, 2021 fd3c8196 View Research
CYCLOPHARM : RESEARCH TIP UPDATES - FEBRUARY 2021 04 Feb, 2021 e5078bbc View Research
CYCLOPHARM: RESEARCH TIP UPDATES - OCTOBER 2020 01 Oct, 2020 eb9a4493 View Research
CYCLOPHARM: RESEARCH TIP UPDATE - JULY 2020 02 Jul, 2020 1dbb92f7 View Research
CYCLOPHARM: RESEARCH TIP UPDATE - MAY 2020 28 May, 2020 61c7cc5c View Research
CYCLOPHARM: RESEARCH TIP UPDATE - 1H20 REPORTING SEASON 12 Mar, 2020 6155aad6 View Research
CYCLOPHARM: RESEARCH TIP UPDATE - NOVEMBER 2019 14 Nov, 2019 44e15ad1 View Research
CYCLOPHARM: RESEARCH TIP UPDATES - JUNE 2019 26 Jun, 2019 4814ba21 View Research
CYCLOPHARM: RESEARCH TIP UPDATES - MAY 2019 15 May, 2019 7ae1af6d View Research
CYCLOPHARM: RESEARCH TIP UPDATES - JANUARY 2019 30 Jan, 2019 a911f5f7 View Research
CYCLOPHARM: RESEARCH TIP UPDATES - JANUARY 2019 16 Jan, 2019 d85fcd9b View Research
CYCLOPHARM: RESEARCH TIP - NOVEMBER 2018 21 Nov, 2018 acb9c574 View Research